Picture of Artelo Biosciences logo

ARTL — Artelo Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Artelo Biosciences To Terminate At-The-Market Offering Agreement Effective May 18, 2026 - SEC Filing

May 15 (Reuters) - Artelo Biosciences Inc ARTL.O:

ARTELO BIOSCIENCES INC - TO TERMINATE AT-THE-MARKET OFFERING AGREEMENT EFFECTIVE MAY 18, 2026 - SEC FILING

Source text: [ID:n0001640334-26-000903]

Further company coverage: ARTL.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Artelo Biosciences

See all news